drugset / Trial / NCT07604974

A Study to Assess the Safety, Tolerability and Efficacy of ION775

NCT07604974 ↗

Phase 2 Recruiting 72 enrolled Ionis Pharmaceuticals, Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

The main objective of this study is to evaluate the effect of ION775 on fasting triglyceride (TG) levels in participants with hypertriglyceridemia (HTG) and severe hypertriglyceridemia (sHTG).

Timeline

Start
2026-05-12
Primary completion
2027-09
Completion
2028-03

Drugs

EvaluationDrugModalityDoseRoute
Subject ION775 Unknown — Subcutaneous

Indications